Recombinant IL23A (Guselkumab Biosimilar) antibody

Catalog No. ABIN7488023

This Mammalian Cells Monoclonal antibody specifically detects IL23A (Guselkumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL23A (Guselkumab Biosimilar) antibody (ABIN7488023)

Target: IL23A (Guselkumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL23A (Guselkumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL23A (Guselkumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Guselkumab Biosimilar - Anti-IL23A mAb

Characteristics: Antibody Type: IgG1-lambda

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 lambda

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL23A (Guselkumab Biosimilar)

Target: IL23A (Guselkumab Biosimilar)

Target Type: Biosimilar

Background: CNTO-1959
Guselkumab is a human IgG1 lambda monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis.

CAS-No: 1350289-85-8